首页> 外文期刊>Cellular and molecular biology >Increased pregnancy rate using standardized coculture on autologous endometrial cells and single blastocyst transfer : a multicentre randomized controlled trial
【24h】

Increased pregnancy rate using standardized coculture on autologous endometrial cells and single blastocyst transfer : a multicentre randomized controlled trial

机译:使用标准共培养自体子宫内膜细胞和单个胚泡转移提高妊娠率:一项多中心随机对照试验

获取原文
获取原文并翻译 | 示例
           

摘要

Despite excellent published results, the lack of well-designed, multicentre, randomized clinical trials results in an absence of general consensus on the efficacy of autologous endometrial cells coculture (AECC) in Assisted Reproductive Technology (ART). An open, multicentre, prospective, randomized controlled trial was designed to compare the pregnancy rate (PR) after the transfer of one blastocyst on day 5 after AECC to the transfer of one embryo on day 3 (control group). Patients were women aged 18 to 36, undergoing an ART cycle with no more than 1 embryo transfer failure. Sample size was calculated at 720 for a superiority trial involving an intermediate analysis at 300 patients. We present the results of the intermediate analysis that resulted in the study ending considering the observed difference. Three hundred thirty nine patients were randomized: 170 in the AECC group and 169 in the control group. The clinical PR per transfer was 53.4% with AECC and 37.3% in the control group (p=0.025). The quality of embryos was improved with AECC. These results suggest that implementation of the AECC technique to a large number of In-Vitro Fertilization (IVF) centres could lead to a substantial improvement in the proportion of successful assisted reproduction. The study was supported by the Laboratoires Genevrier, France.
机译:尽管发表了出色的研究成果,但缺乏精心设计的多中心随机临床试验导致对自体子宫内膜细胞共培养(AECC)在辅助生殖技术(ART)中的功效缺乏普遍共识。设计了一项开放,多中心,前瞻性,随机对照试验,比较AECC后第5天的一个胚泡转移后与第3天的一个胚胎转移后的妊娠率(PR)。患者是年龄在18到36岁之间的女性,经历了一次ART周期且胚胎移植失败不超过1次。对于一项包括300例患者的中间分析的优势试验,样本量计算为720。我们介绍了中间分析的结果,该结果导致考虑到观察到的差异而使研究结束。 339例患者被随机分组​​:AECC组170例,对照组169例。 AECC每次转移的临床PR为53.4%,对照组为37.3%(p = 0.025)。 AECC改善了胚胎的质量。这些结果表明,将AECC技术应用于大量体外受精(IVF)中心可能会大大提高成功辅助生殖的比例。该研究得到了法国实验室实验室的支持。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号